Increase the likelihood of seamless trial conduct with Fortrea. Apply a science-driven approach to navigate the challenges of neuroscience clinical trials.
Through all clinical trial phases, let Fortrea be your trusted source for conducting renal studies. Our medical and operational experience encompasses a broad range of nephrology indications.
Optimize site selection and patient recruitment with our rich database of site-specific recruitment performance. Empower your liver disease clinical trials with our comprehensive medical, scientific and regulatory expertise.
Jill Gicking McConnell is the Chief Financial Officer of Fortrea (Nasdaq: FTRE). She has served in this position since Fortrea’s launch as an independent company in July 2023 following its spinoff from Labcorp (NYSE: LH).
Georgina Strickland is Chief of Staff and Head of Strategy at Fortrea, leading the development of corporate strategy. She has served in this position since Fortrea’s launch as an independent company in July 2023.
Drayton Virkler is President and Chief Commercial Officer at Fortrea, focused on improving the probability of success of biopharmaceutical companies across the globe as they bring life-saving and life-enhancing products to the market.
David Cooper has served as Fortrea’s Chief Administrative Officer since May 2023, responsible for Human Resources, Procurement, Facilities and Corporate Communications.
Our endocrinology professionals leverage their extensive diabetes and lipid disorder experience to help you create streamlined solutions. Learn more here.
